The Tax Benefits of Direct Indexing: Not a One-Size-Fits-All Formula
The Journal of Beta Investment Strategies · 2022
DOI: 10.3905/jbis.2022.1.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Beta Investment Strategies, 2022. Verfasst von Nathan Sosner und 2 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Direct-indexing strategies realize tax benefits by harvesting losses on individual stock positions. Some investors might benefit from this powerful tool for growing after-tax wealth significantly more than others. An important determinant of the tax benefits of direct-indexing strategies is the tax rates applicable to gains from other investments. We argue that high-net-worth investors with allocations to hedge funds and derivatives are the most likely investors to have systematic short-term capital gains and, therefore, derive the highest tax benefits from direct-indexing strategies. We use a long history of U.S. stock returns to estimate the level of tax benefits offered by direct-indexing strategies under different tax rate assumptions. We show that investors, even those without short-term capital gains in their portfolios, can significantly increase the tax benefits of direct indexing by regular capital contributions and charitable giving of appreciated stocks. A character-deferral decomposition of the tax benefits helps explain what drives this result.
Zitieren
APA
Sosner, N., Gromis, M., & Krasner, S. (2022). The Tax Benefits of Direct Indexing: Not a One-Size-Fits-All Formula. The Journal of Beta Investment Strategies. https://doi.org/10.3905/jbis.2022.1.001
Vancouver
Sosner N, Gromis M, Krasner S. The Tax Benefits of Direct Indexing: Not a One-Size-Fits-All Formula. The Journal of Beta Investment Strategies. 2022. doi:10.3905/jbis.2022.1.001
BibTeX
@article{Sosner2022,
author = {Sosner, Nathan and Gromis, Michael and Krasner, Stanley},
title = {The Tax Benefits of Direct Indexing: Not a One-Size-Fits-All Formula},
journal = {The Journal of Beta Investment Strategies},
year = {2022},
doi = {10.3905/jbis.2022.1.001}
}
EUVIMED